The Reduction of Serum Soluble Flt-1 in Patients With Neovascular Age-Related Macular Degeneration
- 1 January 2015
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 159 (1) , 92-100.e2
Abstract
No abstract availableKeywords
Funding Information
- Queen's University Belfast
- Bausch and Lomb
- Novartis
- Bayer
- NIH (R01EY0179500)
- Research to Prevent Blindness, Inc
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- National Institutes of Health
This publication has 41 references indexed in Scilit:
- Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular DegenerationOphthalmology, 2014
- Genetic and Environmental Risk Factors for Age-Related Macular Degeneration in Persons 90 Years and OlderInvestigative Ophthalmology & Visual Science, 2014
- Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) StudyOphthalmology, 2014
- Superoxide Dismutase1 Levels in North Indian Population with Age-Related Macular DegenerationOxidative Medicine and Cellular Longevity, 2013
- Intravitreal Injection of Ranibizumab for Treatment of Age-Related Macular Degeneration: Effects on Serum VEGF ConcentrationCurrent Eye Research, 2013
- Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1eLife, 2013
- Causes and Prevalence of Visual Impairment Among Adults in the UnitedStatesArchives of Ophthalmology (1950), 2004
- Association Between C-Reactive Protein and Age-Related Macular DegenerationJAMA, 2004
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.2000